» Articles » PMID: 29932857

The Use and Abuse of Human Growth Hormone in Sports

Overview
Journal Sports Health
Publisher Sage Publications
Specialty Orthopedics
Date 2018 Jun 23
PMID 29932857
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Recombinant human growth hormone (rHGH) has become a target of abuse in the sporting world. Conversely, sports medicine clinicians may encounter athletes using rHGH to achieve normalcy in the context of growth hormone (GH) deficiency.

Evidence Acquisition: Medline and PubMed databases were queried using the following keywords: GH, GH physiology, GH deficiency, acromegaly, GH athlete, GH sports, GH athletic performance, and GH deficiency concussion. Articles focusing on GH physiology, deficiency, excess, and its effects in both deficient and healthy patients were included.

Study Design: Clinical review.

Level Of Evidence: Level 3.

Results: GH is a naturally occurring hormone with important roles in human physiology. Patients with GH deficiency (GHD) present variably, and GHD has numerous etiologies. rHGH treatment has substantial therapeutic benefits for patients with GHD. The benefits of rHGH treatment in otherwise-healthy adults are uncertain. GH excess may cause health problems such as acromegaly. Professional, collegiate, and international sports leagues and associations have banned rHGH use to maintain athlete health, safety, and fair play. Athletes misusing GH may face prolonged suspensions from competition. Implementing GH abuse testing is challenging, but new methods, such as the biomarker testing procedure, are being finalized.

Conclusion: rHGH is not only an important therapeutic agent for GH-deficient patients but also a target of abuse in competitive athletics. Its benefits in a healthy, adult population are uncertain. A safe exercise and competition plan, developed with a physician knowledgeable of GH use, physiology, and abuse potential, should be of benefit to a longitudinal clinician-patient relationship.

Citing Articles

Safety Implications of Off-Label Medication Use in Athletes: A Narrative Review.

Silva V, Madeira R, Joaquim J, Matos C Medicines (Basel). 2024; 11(8).

PMID: 39584970 PMC: 11627157. DOI: 10.3390/medicines11080020.


Study of the Effect of Phosvitin as a Potential Carrier on the Permeation Process of Somatotropin (STH) and Corticotropin (ACTH) from Biodegradable Polymers Used as Vehicles for STH and ACTH in Semi-Solid Formulations for Skin Application.

Siemiradzka W, Kedzierska K, Rynk W, Dolinska B Polymers (Basel). 2024; 16(18).

PMID: 39339104 PMC: 11436162. DOI: 10.3390/polym16182640.


Performance-Enhancing Drugs in Healthy Athletes: An Umbrella Review of Systematic Reviews and Meta-analyses.

Warrier A, Azua E, Kasson L, Allahabadi S, Khan Z, Mameri E Sports Health. 2023; 16(5):695-705.

PMID: 37688400 PMC: 11346223. DOI: 10.1177/19417381231197389.


A Comprehensive Assessment of Knowledge, Attitudes, and Practicalities Related to Doping Agents use among Jordanians.

Odeh M, Tailakh H, Al Bawab A, Elsahoryi N, Alzoubi K Clin Pract Epidemiol Ment Health. 2023; 18:e174501792202280.

PMID: 37274850 PMC: 10156043. DOI: 10.2174/17450179-v18-e2202280.


Insights into Pathogenesis, Nutritional and Drug Approach in Sarcopenia: A Systematic Review.

Haber Mellen R, Girotto O, Marques E, Fornari Laurindo L, Grippa P, Mendes C Biomedicines. 2023; 11(1).

PMID: 36672642 PMC: 9856128. DOI: 10.3390/biomedicines11010136.


References
1.
Xue P, Wang Y, Yang J, Li Y . Effects of growth hormone replacement therapy on bone mineral density in growth hormone deficient adults: a meta-analysis. Int J Endocrinol. 2013; 2013:216107. PMC: 3652209. DOI: 10.1155/2013/216107. View

2.
Kelestimur F, Tanriverdi F, Atmaca H, Unluhizarci K, Selcuklu A, Casanueva F . Boxing as a sport activity associated with isolated GH deficiency. J Endocrinol Invest. 2005; 27(11):RC28-32. DOI: 10.1007/BF03345299. View

3.
Liu H, Bravata D, Olkin I, Friedlander A, Liu V, Roberts B . Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med. 2008; 148(10):747-58. DOI: 10.7326/0003-4819-148-10-200805200-00215. View

4.
Elliot D, Goldberg L, Moe E, Defrancesco C, Durham M, McGinnis W . Long-term Outcomes of the ATHENA (Athletes Targeting Healthy Exercise & Nutrition Alternatives) Program for Female High School Athletes. J Alcohol Drug Educ. 2008; 52(2):73-92. PMC: 2598770. View

5.
Molitch M, Clemmons D, Malozowski S, Merriam G, Vance M . Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(6):1587-609. DOI: 10.1210/jc.2011-0179. View